Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raza M Alvi

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cancers|August 12, 2022
The Prediction of Cardiac Events Using Contemporary Risk Prediction Models after Radiation Therapy for Head and Neck CancerRaza M Alvi, Thiago Quinaglia, Aferdita Spahillari, et al.
Journal of the American Heart Association|November 16, 2020
Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated MyocarditisZsofia D Drobni, Amna Zafar, Leyre Zubiri, et al.
Journal for Immunotherapy of Cancer|June 19, 2021
Pericardial disease in patients treated with immune checkpoint inhibitorsJingyi Gong, Zsofia Dora Drobni, Amna Zafar, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2021
Immune checkpoint inhibitors for cancer and venous thromboembolic eventsJingyi Gong, Zsofia D Drobni, Raza M Alvi, et al.
JACC. Cardiooncology|April 5, 2021
The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary VasospasmAmna Zafar, Zsofia D Drobni, Ramya Mosarla, et al.
Immunotherapy Advances|September 20, 2021
Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitorsZsofia D Drobni, Sean P Murphy, Raza M Alvi, et al.
Circulation|October 2, 2020
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic PlaqueZsofia D Drobni, Raza M Alvi, Jana Taron, et al.
Plos One|August 4, 2023
Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survivalMalek Z O Hassan, Ahmed Tawakol, Ying Wang, et al.
JACC. Cardiooncology|January 13, 2023
Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After ImmunotherapyCharlotte Lee, Zsofia D Drobni, Amna Zafar, et al.
Nature Communications|January 30, 2021
Deep convolutional neural networks to predict cardiovascular risk from computed tomographyRoman Zeleznik, Borek Foldyna, Parastou Eslami, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancers|August 12, 2022
The Prediction of Cardiac Events Using Contemporary Risk Prediction Models after Radiation Therapy for Head and Neck CancerRaza M Alvi, Thiago Quinaglia, Aferdita Spahillari, et al.
Journal of the American Heart Association|November 16, 2020
Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated MyocarditisZsofia D Drobni, Amna Zafar, Leyre Zubiri, et al.
Journal for Immunotherapy of Cancer|June 19, 2021
Pericardial disease in patients treated with immune checkpoint inhibitorsJingyi Gong, Zsofia Dora Drobni, Amna Zafar, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2021
Immune checkpoint inhibitors for cancer and venous thromboembolic eventsJingyi Gong, Zsofia D Drobni, Raza M Alvi, et al.
JACC. Cardiooncology|April 5, 2021
The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary VasospasmAmna Zafar, Zsofia D Drobni, Ramya Mosarla, et al.
Immunotherapy Advances|September 20, 2021
Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitorsZsofia D Drobni, Sean P Murphy, Raza M Alvi, et al.
Circulation|October 2, 2020
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic PlaqueZsofia D Drobni, Raza M Alvi, Jana Taron, et al.
Plos One|August 4, 2023
Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survivalMalek Z O Hassan, Ahmed Tawakol, Ying Wang, et al.
JACC. Cardiooncology|January 13, 2023
Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After ImmunotherapyCharlotte Lee, Zsofia D Drobni, Amna Zafar, et al.
Nature Communications|January 30, 2021
Deep convolutional neural networks to predict cardiovascular risk from computed tomographyRoman Zeleznik, Borek Foldyna, Parastou Eslami, et al.
Pageof 3